ResearcherUniversity Hospital Schleswig-HolsteinActive in the last 2 years
Jens Uwe Marquardt
Matched on ORCID iD 0000-0002-8314-2682; OpenAlex author ID A5102707966. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2022: 1 paper · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 8
- Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41698-026-01663-z↗
- Intrapancreatic Fat and Risk of Pancreatic Ductal Adenocarcinoma-Pathophysiology, Clinical Implications, and Future Directions. Co-author DOI 10.3390/ijms27187991↗
- Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor differentiation and therapy. Co-author DOI 10.1016/j.ejca.2025.115561↗
- RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. Last author DOI 10.3390/biomedicines12010199↗
- Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant… Last author DOI 10.3390/cancers15030581↗
- TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation. Last author DOI 10.3390/cancers15153791↗
- Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Co-author DOI 10.3390/cells12040587↗
- Suppressive Role of ACVR1/ALK2 in Basal and TGFβ1-Induced Cell Migration in Pancreatic Ductal Adenocarcinoma Cells and Identification of a Self-Perpetuating Au… Last author DOI 10.3390/biomedicines10102640↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rüdiger Braun · 7 shared papers, 2022–2026 · strength 1.49
- Paper Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor dif… DOI 10.1016/j.ejca.2025.115561↗
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Hendrik Ungefroren · 6 shared papers, 2022–2025 · strength 1.27
- Paper Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor dif… DOI 10.1016/j.ejca.2025.115561↗
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Hendrik Lehnert · 5 shared papers, 2022–2026 · strength 1.26
- Paper Intrapancreatic Fat and Risk of Pancreatic Ductal Adenocarcinoma-Pathophysiology, Clinical Implications, and Future Dir… DOI 10.3390/ijms27187991↗
- Paper Regulation of epithelial-mesenchymal plasticity in pancreatic ductal adenocarcinoma: Role of key molecules in tumor dif… DOI 10.1016/j.ejca.2025.115561↗
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Ulrich Friedrich Wellner · 6 shared papers, 2022–2026 · strength 1.22
- Paper RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Mo… DOI 10.3390/biomedicines12010199↗
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Tobias Keck · 3 shared papers, 2023–2026 · strength 0.59
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Elucidation of the Role of SMAD4 in Epithelial-Mesenchymal Plasticity: Does It Help to Better Understand the Consequenc… DOI 10.3390/cancers15030581↗
- Paper Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Prec… DOI 10.3390/cells12040587↗
- Louisa Bolm · 2 shared papers, 2023–2026 · strength 0.37
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Prec… DOI 10.3390/cells12040587↗
- Kim C. Honselmann · 2 shared papers, 2023–2026 · strength 0.37
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Prec… DOI 10.3390/cells12040587↗
- Benedikt Färber · 2 shared papers, 2023–2026 · strength 0.37
- Paper Tumor slice cultures enable rapid ex vivo profiling of patient-specific drug sensitivity in pancreatic ductal adenocarc… DOI 10.1038/s41698-026-01663-z↗
- Paper Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Prec… DOI 10.3390/cells12040587↗
- Svenja Meyhöfer · 1 shared paper, 2026 · strength 0.36
- Holger Kalthoff · 1 shared paper, 2025 · strength 0.27
- Qi Ling · 1 shared paper, 2025 · strength 0.27
- Benjamin Heckelmann · 1 shared paper, 2026 · strength 0.22
- Corinna Ulrike Keber · 1 shared paper, 2026 · strength 0.22
- Steffen Deichmann · 1 shared paper, 2026 · strength 0.22
- Christoph Röcken · 1 shared paper, 2026 · strength 0.22
- Anna Maxi Wandmacher · 1 shared paper, 2026 · strength 0.22
- Annika Bräuer · 1 shared paper, 2026 · strength 0.22
- Susanne Sebens · 1 shared paper, 2026 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.